(EMAILWIRE.COM, November 01, 2019 ) The organ preservation market is poised to reach USD 241.2 Million by 2021, growing at a CAGR of 7.8%, during the forecast period of 2016 to 2021.

The growth of the overall market can be contributed to rising multi-organ failure cases in aging population, technological advancements, increasing government initiatives to promote organ donation and rising number of solid-organ transplant procedures.

In the coming years, the market is expected to witness the highest growth rate in the Asia-Pacific region. North America is expected to account for the largest share of the global market. However, high cost of transplantation is likely to restrain the growth of the market during the forecast period.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=261269915

The organ preservation market comprises of small and big players such as Organ Recovery Systems, Inc. (U.S.), Xvivo Perfusion AB (Sweden), Essential Pharmaceuticals, LLC (U.S.), Transmedics, Inc. (U.S.), Paragonix Technologies, Inc. (U.S), 21st Century Medicine, Inc.(U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Preservation Solutions, Inc. (U.S.), OrganOx Limited (U.K), and Bridge to Life, Ltd. (U.S.)and Waters Medical Systems, LLC (U.S.)

Client acquisitions, approvals & certifications, market expansions, and other (product launches and integrations, agreements, and contracts) are the major developments undertaken by the players to achieve growth in this market. Client acquisitions accounted for ~41% of the total developments undertaken by the players in this market. Some of the significant client acquisitions have been experienced by Lifeline Scientific, Inc. (U.S.) and Transmedics, Inc., (U.S.) OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Hibernicor LLC (U.S.).

Approvals & Certifications accounted for ~38% of the total key developments in the market from January 2013 to May 2016. Paragonix Technolgies, Inc. (U.S.), Lifeline Scientific, Inc. (U.S.), OrganOx, Ltd. (U.K), Organ Assist (Netherlands) and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. One of the significant approvals was witnessed by Lifeline Scientific, Inc. from China’s Food and Drug Administration (CFDA) approving LifePort Kidney Transporter.

Market expansions accounted for ~9% of the total key developments in the organ preservation market between January 2013 and May 2016. Hemarina SA (France), Lifeline Scientific, Inc. (U.S.), and Dr. Franz Kohler Chemie GmbH (Germany) were the key players that carried out these developments. Players adopted this strategy to strengthen their networks, increase their global presence, enhance customer experience, and improve relationships with customers.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=261269915

Other developments such as product launches and integrations, agreements, and contracts, accounted for ~12% of the total key developments in the organ preservation market between January 2013 and May 2016.

XVIVO Perfusion AB (Sweden), Paragonix Technologies, Inc. (U.S.), and Hemarina SA (France) were the key players that carried out these developments.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com